Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease

MLA

Thierry Lobbedez, et al. Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease. Mar. 2019. EBSCOhost, https://doi.org/10.1159/000497352⟩.

APA

Thierry Lobbedez, Rémy Morello, Muaweah Alsaleh, Joëlle Lebreuilly, Angélique Lecouf, & Ludivine Videloup. (2019). Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease. https://doi.org/10.1159/000497352⟩

Chicago

Thierry Lobbedez, Rémy Morello, Muaweah Alsaleh, Joëlle Lebreuilly, Angélique Lecouf, and Ludivine Videloup. 2019. “Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease,” March. doi:10.1159/000497352⟩.